Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.95 | 1.68 |
NAV | ₹21.80 | ₹206.36 |
Fund Started | 17 Aug 2018 | 20 Aug 2004 |
Fund Size | ₹2885.87 Cr | ₹15687.54 Cr |
Exit Load | For units more than 12% of the investments, an exit load of 1% if redeemed within 12 months. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 10.46% | 16.31% |
3 Year | 11.75% | 21.74% |
5 Year | 13.68% | 22.07% |
1 Year
3 Year
5 Year
Equity | 96.29% | 83.94% |
Cash | 3.71% | 15.74% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.47% |
Reliance Industries Ltd. | 4.08% |
Kotak Mahindra Bank Ltd. | 3.69% |
Axis Bank Ltd. | 3.67% |
ICICI Bank Ltd. | 3.53% |
ITC Ltd. | 3.00% |
Maruti Suzuki India Ltd. | 2.99% |
Tata Consultancy Services Ltd. | 2.68% |
Piramal Pharma Ltd. | 2.61% |
Larsen & Toubro Ltd. | 2.49% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.18% |
HDFC Bank Ltd. | 8.88% |
Axis Bank Ltd. | 8.49% |
Maruti Suzuki India Ltd. | 4.90% |
SBI Life Insurance Company Ltd. | 4.26% |
Kotak Mahindra Bank Ltd. | 4.24% |
Cipla Ltd. | 3.96% |
Bharti Airtel Ltd. | 3.63% |
HCL Technologies Ltd. | 3.41% |
Piramal Pharma Ltd. | 3.12% |
Name | Abhinav Sharma | Dhruv Muchhal |
Start Date | 18 Jun 2018 | 22 Jun 2023 |
Name
Start Date
Description | The Scheme aims to generate capital appreciation by investing in a diversified portfolio of equity & equity related instruments across market capitalization. The scheme will predominantly invest in equity and equity related instruments of well researched and growth oriented companies. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 17 Aug 2018 | 20 Aug 2004 |
Description
Launch Date